Portfolio company
Axo Neurotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops biohybrid neural interfaces using cultured cells and flexible electronics for patients with nervous system conditions and human-machine interaction markets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AXO
This company develops neural interfaces designed to integrate with human biology for medical and scientific organisations.
Axoft
This company develops ultra-soft, bio-inspired brain-machine interfaces and neural implants for patients with neurological disorders such as paralysis and neurodegenerative diseases.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Blackrock Neurotech
This company develops implantable brain-computer interface technology and neurophysiology tools for researchers and patients with neurological disorders or paralysis.
Neurosoft Bioelectronics
This company develops soft, stretchable implantable electrodes and brain-computer interfaces for healthcare providers to treat patients with neurological disorders like epilepsy and tinnitus.
Neurotechnology company
This enterprise develops brain-computer interfaces for clinical research and patients with neurological conditions to restore communication and motor control through neural activity monitoring.
Phantom Neuro
This company develops minimally invasive neural interfaces that enable intuitive control of robotic prosthetic limbs and exoskeletons for people with limb loss.
Neurobioniocs
The company develops flexible bioelectronic fibers that deliver neuromodulation therapy through blood vessels for patients with neurological disorders.
